http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105456244-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f9680f0eb74959416e90c37725afc92a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 |
| filingDate | 2015-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7ef5637d0aa37a158093971512e5d11 |
| publicationDate | 2016-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105456244-A |
| titleOfInvention | Application of Flabelliferin A in preparation of platelet improving drugs |
| abstract | The invention relates to a novel use of a compound Flabelliferin A in the pharmaceutical field and relates to application of Flabelliferin A in preparation of platelet improving drugs. The application of Flabelliferin A in preparation of drugs for treating thrombocytopenia is disclosed for the first time. Flabelliferin A has a brand-new skeleton type and unexpected activity in treating thrombocytopenia, likelihood that other compounds give any indication is zero, and Flabelliferin A has outstanding substantive characteristics and has significant progress in controlling thrombocytopenia. |
| priorityDate | 2015-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.